Clinical Trial Update: A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II

View source ↗

Summary

This document reports an update from a completed clinical trial evaluating lanadelumab in individuals with hereditary angioedema type I or II.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• Lanadelumab (lanadelumab)

Snippet

Sponsor: Shire | Conditions: Hereditary Angioedema (HAE) | Status: COMPLETED